ordinary shares on the Stock Exchange Of Thailand (the “SET”) (“Spin-Off Plan”) will take place after 1) EP has obtained the approval for offering newly issued share from the Office of the Securities and
. However, the Company does not require to seek approval from shareholders on this issue. 4. Total Asset and Investment Hospital building, medical equipment, medical supplies, in amount of Baht 133,583,482
entire business transfer by a public company pursuant to Section 107 of the Public Limited Companies Act B.E. 2535 (1992) (as amended). Therefore, the Company is required to seek approval from a
Exchange Commission (SEC) through one offering or partially offering and/or offering program and/or occasionally offering, starting from the SEC approval date Offer locally and/or internationally to general
there is any progress, the Company shall further inform the shareholders. 2. Approval for the determination of authorized directors who sign to bind the Company, which shall be effective from 1 June 2020
than Baht 65,000,000. Therefore, the selling price will be Baht 9,000,000 in total and no Price Adjustment is made. Important condition precedents 1. The Company has obtained approval granted by the
Thailand (“SET”) and shall require the approval from the shareholders’ meeting of the Company, along with the appointment of an Independent Financial Advisor (“IFA”) for entering into such Transaction and
shareholding (Rights Offering) to pay for the existing ordinary shares of IGE. (as the detail in Clause 9). Therefore, the approval of the shareholders' meeting of the acquisition of IGE’s existing ordinary
Baht 256,500,000 as per the Sale of Shares Agreement of NU dated 13 July 2018, with the precedent condition that the Company as the seller must receive the approval from the Board of Directors before